Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

New York, NY

Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.

gilgameshpharmaceutical.com

Company Details

Founded

2019

Employees

Between 10 - 50 employees

Raised

$82,559,840

Headquarters Location

New York, NY

Public

No

Acquired

No

CEO

Jonathan SpornJonathan Sporn

Founders

Mike Cunningham
Mike Cunningham
Andrew Kruegel
Andrew Kruegel
Jeff Witkin
Dalibor Sames
Jonathan Sporn
Jonathan Sporn

Company Collections

These are collections Gilgamesh Pharmaceuticals is a part of. Click on the collection name to view similar companies.

Gilgamesh Pharmaceuticals' Investors

Gilgamesh Pharmaceuticals' Industries